Olympia Compounding Pharmacy dba Olympia SB-5 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE recall — FDA D-0900-2022
Lack of assurance of sterility.
Complete FDA and NHTSA recall records dated in June 2022.
These records include useful source details for the selected month.
Lack of assurance of sterility.
Lack of assurance of sterility.
Mislabeling: The active ingredient list on the label does not match the product's actual ingredients Specifically, the label states Octinoxate 7.5% and Oxybenzone 3%, while the product…
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct…
Lack of assurance of sterility.
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg…
Lack of assurance of sterility.
Lack of assurance of sterility.
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg…
Lack of assurance of sterility.
Defective Delivery System: customer complaints exceeded respective action limits.
Lack of assurance of sterility.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.